These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 38482398)

  • 1. Disulfidptosis and ferroptosis related genes predict prognosis and personalize treatment for hepatocellular carcinoma.
    Liu JF; Huang L; Zhou XP; Li CR; Liu MF; Liang YH; Yu QH; Wu JR
    Transl Cancer Res; 2024 Feb; 13(2):496-514. PubMed ID: 38482398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disulfidptosis characterizes the tumor microenvironment and predicts immunotherapy sensitivity and prognosis in bladder cancer.
    Pan G; Xie H; Xia Y
    Heliyon; 2024 Feb; 10(3):e25573. PubMed ID: 38356551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel application of the ferroptosis-related genes risk model associated with disulfidptosis in hepatocellular carcinoma prognosis and immune infiltration.
    Wei J; Wang J; Chen X; Zhang L; Peng M
    PeerJ; 2024; 12():e16819. PubMed ID: 38317842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of a ferroptosis-related signature for prediction of the prognosis and tumor microenvironment in patients with chromophobe renal cell carcinoma.
    Liu S; Yao Y; Hou M; Mei J; Sun L; Zhang G
    BMC Cancer; 2023 Nov; 23(1):1079. PubMed ID: 37940859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance Analysis.
    Wang W; Pan F; Lin X; Yuan J; Tao C; Wang R
    Front Genet; 2022; 13():907331. PubMed ID: 35938001
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioinformatics-based analysis of the relationship between disulfidptosis and prognosis and treatment response in pancreatic cancer.
    Xiong Y; Kong X; Mei H; Wang J; Zhou S
    Sci Rep; 2023 Dec; 13(1):22218. PubMed ID: 38097783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of a novel ferroptosis-related gene signature for prognosis and potential therapeutic target prediction in cholangiocarcinoma.
    Sae-Fung A; Mutirangura A; Jitkaew S
    Front Immunol; 2022; 13():1051273. PubMed ID: 36733386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
    Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
    Front Immunol; 2021; 12():719175. PubMed ID: 34603293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of ferroptosis and drug resistance related hub genes to predict the prognosis in Hepatocellular Carcinoma.
    Li C; Cui X; Li Y; Guo D; He S
    Sci Rep; 2023 May; 13(1):8681. PubMed ID: 37248280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma.
    Xu L; Zheng Q; Liu W
    BMC Cancer; 2022 Mar; 22(1):229. PubMed ID: 35236323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constructing a disulfidptosis-related prognostic signature of hepatocellular carcinoma based on single-cell sequencing and weighted co-expression network analysis.
    Tian Z; Song J; She J; He W; Guo S; Dong B
    Apoptosis; 2024 May; ():. PubMed ID: 38760515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a Novel Ferroptosis-Related Gene Prognostic Signature in Bladder Cancer.
    Sun J; Yue W; You J; Wei X; Huang Y; Ling Z; Hou J
    Front Oncol; 2021; 11():730716. PubMed ID: 34557413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating bioinformatics and experimental validation to unveil disulfidptosis-related lncRNAs as prognostic biomarker and therapeutic target in hepatocellular carcinoma.
    Xu L; Chen S; Li Q; Chen X; Xu Y; Zhou Y; Li J; Guo Z; Xing J; Chen D
    Cancer Cell Int; 2024 Jan; 24(1):30. PubMed ID: 38218909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a Ferroptosis-Related Long Noncoding RNA Prognostic Signature and Its Predictive Ability to Immunotherapy in Hepatocellular Carcinoma.
    Wang L; Ge X; Zhang Z; Ye Y; Zhou Z; Li M; Yan H; Wu L; Bai Q; Li J; Zhu J; Wang Y
    Front Genet; 2021; 12():682082. PubMed ID: 34745200
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification and characterization of a novel molecular classification based on disulfidptosis-related genes to predict prognosis and immunotherapy efficacy in hepatocellular carcinoma.
    Yang L; Zhang W; Yan Y
    Aging (Albany NY); 2023 Jul; 15(13):6135-6151. PubMed ID: 37399661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disulfidptosis-related genes of prognostic signature and immune infiltration features in hepatocellular carcinoma supported by bulk and single-cell RNA sequencing data.
    Wang Y; Yuan Z; Zhu Q; Ma J; Lu Q; Xiao Z
    J Gastrointest Oncol; 2024 Feb; 15(1):377-396. PubMed ID: 38482234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel ferroptosis-related gene signature associated with prognosis, the immune landscape, and biomarkers for immunotherapy in ovarian cancer.
    Liu Y; Du S; Yuan M; He X; Zhu C; Han K; Zhu Y; Yang Q; Tong R
    Front Pharmacol; 2022; 13():949126. PubMed ID: 36386203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferroptosis and cuproptosis prognostic signature for prediction of prognosis, immunotherapy and drug sensitivity in hepatocellular carcinoma: development and validation based on TCGA and ICGC databases.
    Ma Q; Hui Y; Huang BR; Yang BF; Li JX; Fan TT; Gao XC; Ma DY; Chen WF; Pei ZX
    Transl Cancer Res; 2023 Jan; 12(1):46-64. PubMed ID: 36760376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel disulfidptosis-related lncRNA signature for predicting prognosis and potential targeted therapy in hepatocellular carcinoma.
    Zhang H; Wang J; Yang M
    Medicine (Baltimore); 2024 Jan; 103(4):e36513. PubMed ID: 38277541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a Novel Ferroptosis-Related Gene Signature for Prognosis and Immunotherapy in Hepatocellular Carcinoma.
    Zhang B; Zhao J; Liu B; Shang Y; Chen F; Zhang S; He J; Fan Y; Tan K
    Front Mol Biosci; 2022; 9():940575. PubMed ID: 35847985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.